Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.42 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24359595 | 0.81 | MEN1 (0.51) | MEN1KMT2AKCNA3HTR1ASLC6A2 | |
| SCHEMBL1475576 | 0.78 | CCR3 (0.65) | SIGMAR1ALDH1A1 | |
| SCHEMBL9022573 | 0.77 | SLC6A4 (0.58) | HTR1ASIGMAR1SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6619435 | 0.77 | GMNN (0.37) | MEN1KMT2AHTR1ASIGMAR1SLC6A2 | |
| SCHEMBL4419973 | 0.77 | L3MBTL3 (0.36) | MEN1KMT2ASLC6A4SLC6A3 | |
| SCHEMBL13949806 | 0.76 | MEN1 (0.49) | MEN1KMT2AKCNA3HTR1ASIGMAR1 | |
| SCHEMBL13499239 | 0.75 | SIGMAR1 (0.66) | MEN1KMT2ASIGMAR1ALDH1A1 | |
| SCHEMBL9595556 | 0.75 | KCNA3 (0.47) | MEN1KMT2AKCNA3HTR1ASIGMAR1 | |
| SCHEMBL24433074 | 0.74 | L3MBTL1 (0.51) | KCNA3ALDH1A1 | |
| SCHEMBL9906607 | 0.74 | KCNA3 (0.59) | MEN1KMT2AKCNA3HTR1ASIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022083679-A1 | PRODRUGS FOR SUSTAINED RELEASING THERAPEUTIC AGENTS AND USES THEREOF | LIANGJIANG MEDICINE CO., LTD. (CN) | 2022-04-28 | — | — | WO | disclosed |